YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Earnings Call Insights: Intensity Therapeutics (INTS) Q2 2026 MANAGEMENT VIEW * "It is my pleasure to provide the latest update of our company's progress in the INVINCIBLE-3 and INVINCIBLE-4 studies, our business development activities, an…
(RTTNews) - Cue Biopharma, Inc. (CUE), a clinical-stage biopharmaceutical company developing therapies for immune-mediated diseases, announced the appointment of James Ahlers as Chief Financial Officer (CFO), effective immediately. Ahlers…
Apple (AAPL) Shares in Apple (AAPL) were higher in pre-market trading following the tech giant's fiscal fourth-quarter results, which exceeded Wall Street's expectations. Apple posted total revenue of $102.5bn (£77bn) for the quarter, mark…
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. [postmarket] AFTER HOURS GAINERS TICKER CHANGE COMMENT THAR [https://www.chartmill.com/stock/quote/THAR/profile] 18.11% THARIMMUNE…
Intensity Therapeutics (NASDAQ:INTS [https://seekingalpha.com/symbol/INTS]) said [https://seekingalpha.com/pr/20197325-intensity-therapeutics-inc-regains-compliance-with-nasdaqs-minimum-stockholders-equity] on Tuesday that the biotechnolog…
* Intensity Therapeutics press release [https://seekingalpha.com/pr/20194119-intensity-therapeutics-reports-second-quarter-2025-financial-results-and-provides-corporate] (NASDAQ:INTS [https://seekingalpha.com/symbol/INTS]): Q2 GAAP EPS of…
Intensity Therapeutics , Inc. (NASDAQ:INTS), a micro-cap biotech company currently valued at $8.36 million with shares trading at $0.33, held its annual meeting of stockholders via live webcast on Thursday. The company’s stock has experien…
* Intensity Therapeutics (NASDAQ:INTS [https://seekingalpha.com/symbol/INTS]) stock price slumped 27% on Wednesday during after market hours of trading as it priced [https://seekingalpha.com/pr/20134342-intensity-therapeutics-inc-announces…
Company poised to accelerate accrual in all clinical programs as it activates numerous sites across multiple U.S. cities and abroad and takes over sponsorship from the investigator-led program Updated interim data for lead iNKT engager, PO…
Portage Biotech, Inc. Company poised to accelerate accrual in all clinical programs as it activates numerous sites across multiple U.S. cities and abroad and takes over sponsorship from the investigator-led program Updated interim data for…